isoproterenol has been researched along with telmisartan in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brockmöller, J; Dücker, C; Gebauer, L; Jensen, O | 1 |
| Arora, S; Arya, DS; Goyal, S; Joshi, S; Kumari, S; Mittal, R; Nag, TC; Ray, R | 1 |
| Hara, Y; Hoshino, Y; Kosaka, N; Okada, M; Yamawaki, H | 1 |
| Guo, BY; Han, DR; Han, R; Li, YJ; Shi, YH; Wang, M; Yang, SL; Zhou, H | 1 |
| Böhm, M; Caglayan, E; Ghanem, A; Gross, ML; Huntgeburth, M; Mödersheim, S; Müller-Ehmsen, J; Rosenkranz, S; Schlüter, KD; Schreckenberg, R; Shahverdyan, R; Tiemann, K; Vantler, M; Zimmermann, WH | 1 |
| Goyal, BR; Mehta, AA | 1 |
1 review(s) available for isoproterenol and telmisartan
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
8 other study(ies) available for isoproterenol and telmisartan
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Substrates and Inhibitors of the Organic Cation Transporter 3 and Comparison with OCT1 and OCT2.
Topics: Biological Transport; Cations; Organic Cation Transport Proteins; Organic Cation Transporter 1; Organic Cation Transporter 2 | 2022 |
Myocardial salvaging effect of telmisartan in experimental model of myocardial infarction.
Topics: Animals; Benzimidazoles; Benzoates; Biomarkers; Body Weight; Cardiotonic Agents; Catalase; Disease Models, Animal; Heart; Isoproterenol; L-Lactate Dehydrogenase; Lipid Peroxidation; Male; Myocardial Infarction; Myocardium; Rats; Rats, Wistar; Superoxide Dismutase; Telmisartan | 2009 |
Effects of captopril and telmisartan on matrix metalloproteinase-2 and -9 expressions and development of left ventricular fibrosis induced by isoprenaline in rats.
Topics: Animals; Benzimidazoles; Benzoates; Captopril; Drug Therapy, Combination; Fibrosis; Gene Expression Regulation, Enzymologic; Isoproterenol; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Random Allocation; Rats; Rats, Wistar; Telmisartan; Ventricular Dysfunction, Left | 2010 |
Telmisartan attenuates isoproterenol-induced cardiac remodeling in rats via regulation of cardiac adiponectin expression.
Topics: Adiponectin; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Heart; Isoproterenol; Male; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; Telmisartan | 2011 |
Transforming growth factor β₁ oppositely regulates the hypertrophic and contractile response to β-adrenergic stimulation in the heart.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Cardiomegaly; Cells, Cultured; Echocardiography, Stress; Gene Expression Regulation; Heart; Humans; Ion Channels; Isoproterenol; Metoprolol; Mice; Mice, Transgenic; Mitochondrial Proteins; Myocardial Contraction; Myocardium; Myocytes, Cardiac; Reverse Transcriptase Polymerase Chain Reaction; Telmisartan; Transforming Growth Factor beta1; Uncoupling Protein 3 | 2011 |
Beneficial role of spironolactone, telmisartan and their combination on isoproterenol-induced cardiac hypertrophy.
Topics: Adrenergic beta-Agonists; Algorithms; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; C-Reactive Protein; Cardiomegaly; Creatine Kinase, MB Form; Disease Models, Animal; Diuretics; Drug Therapy, Combination; Dyslipidemias; Hemodynamics; Injections, Intraperitoneal; Isoproterenol; Rats; Rats, Wistar; Spironolactone; Telmisartan; Treatment Outcome | 2012 |